Navigation Links
Verdan Receives Patent on Crystal Deodorant Spray
Date:2/22/2010

Verdan, the premier supplier of natural crystal deodorant products to the cosmetic industry, received a patent on its crystal deodorant spray, MineralProtect™. MineralProtect™ combines purified alpine fresh water and translucent natural deodorant crystals, and is complemented by an advanced spray mechanism that provides the user with liquid crystal deodorant and proven 24 hour odor prevention.

(PRWEB) February 22, 2010 -- Verdan, the premier supplier of natural crystal deodorant products to the cosmetic industry, announced that it received a patent on its crystal deodorant spray, MineralProtect™, which incorporates an advanced spray mechanism of highly saturated natural liquid crystal deodorant. Verdan applied for this patent in 2007, citing the spray bottle’s design and ability to effectively extract and dispense the liquid crystal deodorant at targeted levels on the skin without the deodorant crystals obstructing and clogging the spray pump. The patent was published and granted in the U.S., Switzerland, France, Germany, Spain, Great Britain and Belgium.

“MineralProtect™ creates a more efficient crystal deodorant spray, effectively allowing for an increased concentration of liquid crystal deodorant that exceeds 12%,” said Francis Verdan, founder of Verdan. “Our newly patented spray successfully provides 24 hour odor prevention without the need of any synthetic ingredients.”

MineralProtect™ is proven by the Dermscan Group through clinical testing and awarded an efficacy certificate stating that it is significantly more efficient than other forms of Verdan crystal deodorant and provides 24 hour odor prevention. Dermscan Group is a leader in pre-clinical and clinical trials for the cosmetic industry.

“This new patent broadens and strengthens our crystal deodorant portfolio and firmly establishes our leadership in developing and supplying innovative and quality odor prevention solutions that are both natural and effective for consumers to use,” said Verdan.

MineralProtect™ is a completely transparent solution that combines purified alpine fresh water and translucent natural deodorant crystals, and is complemented by an advanced spray mechanism. MineralProtect™ is a registered trademark in the U.S. and is available for private labeling in the original unscented formula, or with the addition of fragrances per the customers’ request. Furthermore, customers have the option to market and sell the product as ECOCERT certified with the inclusion of 5-10% “Eau Florale.”

The active ingredient in MineralProtect™, as well as the complete line of Verdan natural crystal deodorants, is crystal alum, which is also known as crystal deodorant stone, or by its mineral name, potassium alum. All Verdan products are made of 100% naturally occurring potassium alum, and are aluminum hydroxide free, opposed to synthetic crystal deodorants that are made by synthesizing aluminum hydroxide with sulfuric acid and adding ammonium sulfate.

Verdan is the premier supplier, OEM and private label natural crystal deodorant. For more than 30 years, Verdan has been providing clients worldwide with exceptional service and the highest quality all-natural crystal deodorants made from 100% potassium alum stone. For more information please visit us at http://www.verdan.net.

###

Read the full story at http://www.prweb.com/releases/crystal_deodorant_stone/spray/prweb3626994.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. WuXi PharmaTech Receives AAALAC Accreditation for Suzhou Toxicology Facility
2. NOVAVAX, Inc. Receives NASDAQ Non-Compliance Letter
3. Special Olympics Georgia Receives Grant from The Home Depot Foundation
4. Oridion Receives Frost & Sullivan's 2010 Customer Value Enhancement Award
5. Corporate Wellness Firm Limeade Receives SAS 70 Type II Report
6. BestMassage.com Receives Award for Customer Trust
7. UT researcher receives $2.4 million to research obesity, high-risk pregnancy
8. Dr Yaghouti of Global Laser Vision Receives Patient's Choice Award for 2009
9. NACDD Receives Two-Year Grant From Merck & Co., Inc. to Improve Diabetes Education
10. Keith Black, M.D. Receives Health Power for Minorities Website Black Heritage Award
11. Speedus Receives and Appeals Nasdaq Notice
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Verdan Receives Patent on Crystal Deodorant Spray
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... a breakthrough topical cream that’s the first in a new class of photodynamic ... the overall appearance of skin, visibly reduce outward signs of aging, and minimize ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... rely on contracted partners to help with process innovation in drug formulation and ... formulation experience along with state-of-the-art analytical equipment in support of their development and ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... India , April 19, 2017 ... and Application, Forecast to 2022 report has covered and analysed ... statistics and information on market size, shares and growth factors. ... major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
Breaking Medicine Technology: